In a feat of computational biology, researchers design novel proteins capable of neutralizing a key influenza protein
The Scientist
Most Recent
The Human Genome Project has generated nearly $800 billion in economic output and hundreds of thousands of jobs in genomics and related industries
A new vaccine that uses a persistent virus vector controlled SIV in 50 percent of tested monkeys
Columbia University evolutionary ecologist Dustin Rubenstein explains just why it's so interesting and important to find slime molds that engage in a form of agriculture.
Does mitochondrial dysfunction lie at the heart of common, complex diseases like cancer and autism?
Clostridium difficile is evolving more robust toxicity, repeatedly attacking its victims, and driving the search for alternative therapies to fight the infection.
By forging new relationships and finding novel uses for existing technologies, this year’s top companies are employing creative ways to advance their science.
A promising gene therapy trial, derailed by cancerous side effects in a young patient, is set to reboot with the help of next generation gene-transfer vectors.
Medical schools in the UK are teaching physiology courses primarily focused on clinical applications with much curtailed practical laboratory training to the detriment of medical education
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
